Patent US5024231A successfully refreshed from Google Patents.
US5024231A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Automated multi-point blood volume analyzer
Assignee: Daxor Corp
•
Filing: 1990-05-14
•
Granted: 1991-06-18
•
Expires: 2010-05-14
Abstract
Abstract A multi-point method of determining a time-zero blood volume by the tracer dilution technique. A tracer is injected into the blood stream of a living being, and a plurality of mixed samples of blood and tracer are removed from the blood stream at a corresponding plurality of measured time intervals subsequent to the injecting step. A blood portion volume corresponding to each time interval is automatically determined from the tracer level in the mixed samples, and a time-zero blood portion volume is automatically calculated from the determined blood portion volumes and time intervals.
Inventors
- 👤 Joseph Feldschuh
- 👤 Jonathan A. Feldschuh
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 20:35
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/15; A61B5/155; A61B5/02; A61B5/02042; A61B5/150007; A61B5/150015; A61B5/15003; A61B5/150755
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
197 words
A multi-point method of determining a time-zero blood volume by the indicator dilution technique comprising the steps of: (A) injecting an indicator into the blood stream of a living being; (B) removing a plurality of mixed samples of blood and indicator from the blood stream at a corresponding plurality of measured time intervals subsequent to the injecting step and determining the hematocrit of each mixed sample; (C) providing means for automatically determining the level of indicator in a plasma portion of each of the mixed samples relative to prepared standards, for automatically calculating for each mixed sample the apparent plasma volume from the indicator level, for automatically calculating for each mixed sample the apparent blood volume from the apparent plasma volume and hematocrit, for automatically calculating a time-zero blood volume from the calculated apparent blood volumes and time intervals, and for recalculating the time-zero blood volume without using any calculated apparent blood volume which reflects an indicator level which is out of line with the others; and (D) providing as input to such means plasma portions of the mixed samples, the hematocrits, and the time intervals and causing said means to automatically calculate the time-zero blood volume.
Claim 2
Dependent Claim
197 words
A multi-point method of determining a time-zero blood volume by the indicator dilution technique comprising the steps of: (A) injecting an indicator into the blood stream of a living being; (B) removing a plurality of mixed samples of blood and indicator from the blood stream at a corresponding plurality of measured time intervals subsequent to the injecting step and determining the hematocrit of each mixed sample; (C) providing means for automatically determining the level of indicator in a plasma portion of each of the mixed samples relative to prepared standards, for automatically calculating for each mixed sample the apparent plasma volume from the indicator level, for automatically calculating for each mixed sample the apparent blood volume from the apparent plasma volume and hematocrit, for automatically calculating a time-zero blood volume from the calculated apparent blood volumes and time intervals, and for recalculating the time-zero blood volume without using any calculated apparent blood volume which reflects an indicator level which is out of line with the others; and (D) providing as input to such means plasma portions of the mixed samples, the hematocrits, and the time intervals and causing said means to automatically calculate the time-zero blood volume.
Claim 3
Dependent Claim
19 words
The method of claim 1 wherein in step (D) the time-zero blood volume is calculated by logarithmic regression analysis.
Claim 4
Dependent Claim
44 words
The method of claim 1 wherein prior to step (D) the blood volume/time interval data is analyzed for general agreement, and any such data not in general agreement with the remainder of such data is disregarded in the determination of the time-zero blood volume.
Claim 5
Dependent Claim
26 words
The method of claim 1 wherein the indicator is a radioactive tracer and in step (C) the determination of the indicator level employs a gamma counter.
Claim 6
Dependent Claim
24 words
The method of claim 4 wherein the tracer is I 131 -tagged serum albumin and the gamma counter is an NaI scintillation gamma counter.
Claim 7
Dependent Claim
14 words
The method of claim 1 wherein in step (B) the time intervals are irregular.
Claim 8
Dependent Claim
18 words
The method of claim 1 wherein said determination of a time-zero blood volume is made in real time.
Claim 9
Dependent Claim
193 words
An automated real-time multi-point, time-zero blood volume analyzer comprising: (A) means for receiving a plasma portion of each of a plurality of mixed samples of blood and an indicator injected into a blood stream from which the sample is taken, the indicator having been injected at a given time and the samples being taken at measured time intervals thereafter; (B) means for receiving data one the time of injection of the indicator into the blood stream, the time of taking each of the mixed samples, and the hematocrit of each of the mixed samples; (C) means for automatically determining the level of indicator in the plasma portion of each of the mixed samples relative to prepared standards, for automatically calculating for each mixed sample the apparent plasma volume from the indicator level, for antomatically calculating for each mixed sample the apparent blood volume from the apparent plasma volume and hematocrit, for automatically calculating a time-zero blood volume from the calculated apparent blood volumes and time intervals, and for recalculating the time-zero blood volume without using any calculated apparent blood volume which reflects an indicator level which is out of line with the others.
Claim 10
Dependent Claim
193 words
An automated real-time multi-point, time-zero blood volume analyzer comprising: (A) means for receiving a plasma portion of each of a plurality of mixed samples of blood and an indicator injected into a blood stream from which the sample is taken, the indicator having been injected at a given time and the samples being taken at measured time intervals thereafter; (B) means for receiving data one the time of injection of the indicator into the blood stream, the time of taking each of the mixed samples, and the hematocrit of each of the mixed samples; (C) means for automatically determining the level of indicator in the plasma portion of each of the mixed samples relative to prepared standards, for automatically calculating for each mixed sample the apparent plasma volume from the indicator level, for antomatically calculating for each mixed sample the apparent blood volume from the apparent plasma volume and hematocrit, for automatically calculating a time-zero blood volume from the calculated apparent blood volumes and time intervals, and for recalculating the time-zero blood volume without using any calculated apparent blood volume which reflects an indicator level which is out of line with the others.
Claim 11
Dependent Claim
75 words
The analyzer of claim 8 further comprising means for receiving an environment background sample, a standard sample, and a control sample, and means for determining as the indicator level in a mixed sample only the excess of the actual indicator level therein over that in the control sample, and means for determining as the indicator level in a standard sample only the excess of the actual indicator level therein over that in the background sample.
Claim 12
Dependent Claim
45 words
The analyzer of claim 8 further comprising means for receiving an environment background sample and a standard sample, and means for determining as the indicator level in a standard sample only the excess of the actual indicator level therein over that in the background sample.
Claim 13
Dependent Claim
30 words
The analyzer of claim 10 wherein said means for determining the indicator level in a mixed sample determines the same by reference to determined indicator levels in a standard sample.
Claim 14
Dependent Claim
30 words
The analyzer of claim 8 further comprising means for receiving data representing the patient's sex, height and weight and for calculating and displaying the ideal blood volume for the patient.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-06-17 | 1994-12-17 | 1995-06-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-06-17 | 1998-12-17 | 1999-06-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-06-17 | 2002-12-17 | 2003-06-18 | $7700.00 | Window Closed / Lapsed |